|
DNAJC28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.56736862272555E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67450000532199E-08 |
| Normal-vs-Stage2 |
1.29190003139712E-09 |
| Normal-vs-Stage3 |
6.66133814775094E-16 |
| Normal-vs-Stage4 |
3.680000E-03 |
| Stage1-vs-Stage2 |
5.714000E-02 |
| Stage1-vs-Stage3 |
2.17309999994697E-06 |
| Stage1-vs-Stage4 |
1.800750E-01 |
| Stage2-vs-Stage3 |
2.386000E-02 |
| Stage2-vs-Stage4 |
6.431200E-01 |
| Stage3-vs-Stage4 |
5.792200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02418074021671E-12 |
| Normal-vs-AfricanAmerican |
8.28630000000441E-05 |
| Normal-vs-Asian |
1.46229999997693E-06 |
| Caucasian-vs-AfricanAmerican |
2.898400E-01 |
| Caucasian-vs-Asian |
4.630400E-01 |
| AfricanAmerican-vs-Asian |
6.546300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22889476372734E-11 |
| Normal-vs-Female |
1.87699966680555E-10 |
| Male-vs-Female |
5.735800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.05479996643277E-09 |
| Normal-vs-Extreme_Weight |
2.8057556278327E-12 |
| Normal-vs-Obese |
4.79609996162367E-09 |
| Normal-vs-Extreme_Obese |
9.314200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.232000E-01 |
| Normal_Weight-vs-Obese |
8.019000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.589000E-01 |
| Extreme_Weight-vs-Obese |
4.981400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.312400E-01 |
| Obese-vs-Extreme_Obese |
2.803000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.117200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.73350017568441E-10 |
| Normal-vs-Age(61-80Yrs) |
2.2004953414978E-11 |
| Normal-vs-Age(81-100Yrs) |
5.29450000508191E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.316800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.463600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.902400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.639200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.695190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.543600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.5005998100246E-11 |
| Normal-VS-Type2 PRCC |
2.99700042560858E-10 |
| Normal-VS-KIRP CIMP |
2.8190783041282E-12 |
| Normal-VS-Unclassified PRCC |
1.52767999999082E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.276800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.209430E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.245000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.168280E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.928600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.807000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72809544451979E-11 |
| Normal-vs-N1 |
1.08120179476145E-11 |
| Normal-vs-N2 |
1.48549994527514E-09 |
| N0-vs-N1 |
1.312830E-01 |
| N0-vs-N2 |
1.54310000000102E-06 |
| N1-vs-N2 |
9.001200E-04 |
|
|
